Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2013

01-06-2013 | Healthcare Policy and Outcomes

Factors Associated with Breast MRI Use: A Population-Based Analysis

Authors: Brigid K. Killelea, MD, Donald R. Lannin, MD, Laura J. Horvath, MD, Nina R. Horowitz, MD, Anees B. Chagpar, MD

Published in: Annals of Surgical Oncology | Issue 6/2013

Login to get access

Abstract

Introduction

Although controversial, the use of breast magnetic resonance imaging (MRI) is widespread. We sought to determine factors that influenced its use in a population-based sample.

Methods

The National Health Interview Survey is conducted annually by the Centers for Disease Control and is designed to be representative of the American population. Data from 2010 were queried for the use of breast MRI and associated sociodemographic and risk characteristics.

Results

Of the 11,222 women aged ≥30 years who were surveyed, 4.7 % reported ever having a breast MRI. Nearly a quarter were done as part of a “routine exam” and <5 % were done for “family history” or for “high risk.” Factors correlating with MRI use on univariate analysis included age, race, personal and/or family history of breast cancer, history of benign breast biopsy, perceived risk, and insurance. On multivariate analysis, African-American race (p = 0.001), personal history (p < 0.001), history of benign biopsy (p < 0.001), and high perceived risk (p < 0.001) were significantly associated with increased MRI use. In a cohort without a personal history of breast cancer, race, history of benign biopsy, and perceived risk were independent correlates of breast MRI, whereas family history, age, and insurance were no longer significant.

Conclusions

Personal history is the strongest factor associated with breast MRI use. However, whereas race, history of benign biopsy, and perceived risk were independently associated with MRI use, family history was not. These findings call into question whether current practice patterns follow evidence-based guidelines.
Literature
1.
go back to reference Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.PubMedCrossRef Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.PubMedCrossRef
3.
go back to reference Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180-7.PubMedCrossRef Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180-7.PubMedCrossRef
4.
go back to reference Hwang N, Schiller DE, Crystal P, et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: Its effect on ipsilateral breast tumor recurrence after breast conservation therapy. Ann Surg Oncol. 2009;16(11):3000-9.PubMedCrossRef Hwang N, Schiller DE, Crystal P, et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: Its effect on ipsilateral breast tumor recurrence after breast conservation therapy. Ann Surg Oncol. 2009;16(11):3000-9.PubMedCrossRef
5.
go back to reference Katipamula R, Degnim AC, Hoskin T, et al. Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging J Clin Oncol. 2009;27(25):4082-8.PubMedCrossRef Katipamula R, Degnim AC, Hoskin T, et al. Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging J Clin Oncol. 2009;27(25):4082-8.PubMedCrossRef
6.
go back to reference Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011;2561(2):421-7.CrossRef Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011;2561(2):421-7.CrossRef
7.
go back to reference Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am. 2010;19(3):475-92.PubMedCrossRef Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am. 2010;19(3):475-92.PubMedCrossRef
8.
go back to reference Kuhl CK, Scrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:458-92. Kuhl CK, Scrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:458-92.
10.
go back to reference Heywang SH, Wolf A, Pruss E, Hilbertz T Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989;171(1):95-103.PubMed Heywang SH, Wolf A, Pruss E, Hilbertz T Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989;171(1):95-103.PubMed
11.
go back to reference D’Orsi CJ, Newell MS. On the frontline of screening for breast cancer. Sem Oncol. 2011;38(1):119-27.PubMedCrossRef D’Orsi CJ, Newell MS. On the frontline of screening for breast cancer. Sem Oncol. 2011;38(1):119-27.PubMedCrossRef
12.
go back to reference Kaiser WA, Zeitler E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA-preliminary observations. Radiology. 1989;179:681-6. Kaiser WA, Zeitler E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA-preliminary observations. Radiology. 1989;179:681-6.
13.
go back to reference Graubard BI, Freedman AN, Gail MH. Five-year and lifetime risk of breast cancer among U.S. Subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev. 2010;19:2428-9.CrossRef Graubard BI, Freedman AN, Gail MH. Five-year and lifetime risk of breast cancer among U.S. Subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev. 2010;19:2428-9.CrossRef
15.
go back to reference Gorechlad JW, McCabe EB, Higgins JH, Likosky DS, Lewis PJ, Rosenkranz KM, Barth RJ. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for breast MRI? Ann Surg Oncol. 2008;15(6):1703-9.PubMedCrossRef Gorechlad JW, McCabe EB, Higgins JH, Likosky DS, Lewis PJ, Rosenkranz KM, Barth RJ. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for breast MRI? Ann Surg Oncol. 2008;15(6):1703-9.PubMedCrossRef
16.
go back to reference Kriege, M, Brekelmans, CT, Boetes, C, Besnard, PE, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004:351:427-37.PubMedCrossRef Kriege, M, Brekelmans, CT, Boetes, C, Besnard, PE, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004:351:427-37.PubMedCrossRef
17.
go back to reference Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-25.CrossRef Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-25.CrossRef
18.
go back to reference Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-76.PubMedCrossRef Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-76.PubMedCrossRef
19.
go back to reference Ickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357.CrossRef Ickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357.CrossRef
20.
go back to reference Sommer, CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS. Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170:77–83.PubMedCrossRef Sommer, CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS. Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170:77–83.PubMedCrossRef
21.
go back to reference El-Bastawissi AY, White E, Mandelson MT, Taplin S. Variation in mammographic breast density by race. Ann Epidemiol. 2001;11(4):257-63.PubMedCrossRef El-Bastawissi AY, White E, Mandelson MT, Taplin S. Variation in mammographic breast density by race. Ann Epidemiol. 2001;11(4):257-63.PubMedCrossRef
Metadata
Title
Factors Associated with Breast MRI Use: A Population-Based Analysis
Authors
Brigid K. Killelea, MD
Donald R. Lannin, MD
Laura J. Horvath, MD
Nina R. Horowitz, MD
Anees B. Chagpar, MD
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2758-8

Other articles of this Issue 6/2013

Annals of Surgical Oncology 6/2013 Go to the issue